Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Ear2 deletion causes early memory and learning deficits in APP/PS1 mice.

Kummer MP, Hammerschmidt T, Martinez A, Terwel D, Eichele G, Witten A, Figura S, Stoll M, Schwartz S, Pape HC, Schultze JL, Weinshenker D, Heneka MT, Urban I.

J Neurosci. 2014 Jun 25;34(26):8845-54. doi: 10.1523/JNEUROSCI.4027-13.2014. Erratum in: J Neurosci. 2015 Feb 4;35(5):2321. Urban, Inga [Added].

2.

Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice.

Hammerschmidt T, Kummer MP, Terwel D, Martinez A, Gorji A, Pape HC, Rommelfanger KS, Schroeder JP, Stoll M, Schultze J, Weinshenker D, Heneka MT.

Biol Psychiatry. 2013 Mar 1;73(5):454-63. doi: 10.1016/j.biopsych.2012.06.013. Epub 2012 Aug 9.

3.

Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.

Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Dyrks T, Thiele A, Heneka MT.

Neurochem Int. 2010 Nov;57(4):375-82. doi: 10.1016/j.neuint.2010.02.001. Epub 2010 Feb 6.

PMID:
20144675
4.

Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.

Sadowski M, Pankiewicz J, Scholtzova H, Ji Y, Quartermain D, Jensen CH, Duff K, Nixon RA, Gruen RJ, Wisniewski T.

J Neuropathol Exp Neurol. 2004 May;63(5):418-28.

5.

Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice.

Saura CA, Chen G, Malkani S, Choi SY, Takahashi RH, Zhang D, Gouras GK, Kirkwood A, Morris RG, Shen J.

J Neurosci. 2005 Jul 20;25(29):6755-64.

6.

Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice.

Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Thiele A, Heneka MT.

Neuroscience. 2011 Mar 10;176:396-407. doi: 10.1016/j.neuroscience.2010.11.052. Epub 2010 Dec 1.

PMID:
21129451
7.

GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin.

Yoshiike Y, Kimura T, Yamashita S, Furudate H, Mizoroki T, Murayama M, Takashima A.

PLoS One. 2008 Aug 21;3(8):e3029. doi: 10.1371/journal.pone.0003029.

8.

Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.

Guo C, Wang T, Zheng W, Shan ZY, Teng WP, Wang ZY.

Neurobiol Aging. 2013 Feb;34(2):562-75. doi: 10.1016/j.neurobiolaging.2012.05.009. Epub 2012 Jun 19.

PMID:
22717236
9.

Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.

Lok K, Zhao H, Zhang C, He N, Shen H, Wang Z, Zhao W, Yin M.

J Neurol Sci. 2013 Dec 15;335(1-2):145-54. doi: 10.1016/j.jns.2013.09.018. Epub 2013 Sep 21.

PMID:
24095271
10.

Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice.

Li PP, Wang WP, Liu ZH, Xu SF, Lu WW, Wang L, Wang XL.

Acta Pharmacol Sin. 2014 Jul;35(7):869-78. doi: 10.1038/aps.2014.29. Epub 2014 May 26.

11.

Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice.

O'Neil JN, Mouton PR, Tizabi Y, Ottinger MA, Lei DL, Ingram DK, Manaye KF.

J Chem Neuroanat. 2007 Nov;34(3-4):102-7. Epub 2007 May 31.

PMID:
17658239
12.

Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels.

Simón AM, Schiapparelli L, Salazar-Colocho P, Cuadrado-Tejedor M, Escribano L, López de Maturana R, Del Río J, Pérez-Mediavilla A, Frechilla D.

Neurobiol Dis. 2009 Mar;33(3):369-78. doi: 10.1016/j.nbd.2008.11.005. Epub 2008 Nov 28.

PMID:
19101630
13.

In vivo hippocampal microdialysis reveals impairment of NMDA receptor-cGMP signaling in APP(SW) and APP(SW)/PS1(L166P) Alzheimer's transgenic mice.

Duszczyk M, Kuszczyk M, Guridi M, Lazarewicz JW, Sadowski MJ.

Neurochem Int. 2012 Dec;61(7):976-80. doi: 10.1016/j.neuint.2012.07.017. Epub 2012 Jul 27.

14.

Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.

Ding Y, Qiao A, Wang Z, Goodwin JS, Lee ES, Block ML, Allsbrook M, McDonald MP, Fan GH.

J Neurosci. 2008 Nov 5;28(45):11622-34. doi: 10.1523/JNEUROSCI.3153-08.2008.

15.

Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.

Jin F, Gong QH, Xu YS, Wang LN, Jin H, Li F, Li LS, Ma YM, Shi JS.

Int J Neuropsychopharmacol. 2014 Jun;17(6):871-81. doi: 10.1017/S1461145713001533. Epub 2014 Feb 11.

PMID:
24513083
16.

Long-term social isolation exacerbates the impairment of spatial working memory in APP/PS1 transgenic mice.

Huang HJ, Liang KC, Ke HC, Chang YY, Hsieh-Li HM.

Brain Res. 2011 Jan 31;1371:150-60. doi: 10.1016/j.brainres.2010.11.043. Epub 2010 Nov 26.

PMID:
21114967
17.
18.

Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.

McClean PL, Hölscher C.

Neuropharmacology. 2014 Jan;76 Pt A:57-67. doi: 10.1016/j.neuropharm.2013.08.005. Epub 2013 Aug 21.

PMID:
23973293
19.

Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.

Nagakura A, Shitaka Y, Yarimizu J, Matsuoka N.

Eur J Pharmacol. 2013 Mar 5;703(1-3):53-61. doi: 10.1016/j.ejphar.2012.12.023. Epub 2012 Dec 28.

PMID:
23276665
20.

Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.

Lewis TL, Cao D, Lu H, Mans RA, Su YR, Jungbauer L, Linton MF, Fazio S, LaDu MJ, Li L.

J Biol Chem. 2010 Nov 19;285(47):36958-68. doi: 10.1074/jbc.M110.127829. Epub 2010 Sep 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk